Deutsche Bank’s Biodesix BDSX Stock Holding History

Deutsche Bank’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-333	Closed	-$11K	–	4133
2022 Q1	$11K	Sell	333 -40	-11%	-$2.61K	﹤0.01%	4114
2021 Q4	$39K	Buy	373 +20	+6%	+$2.61K	﹤0.01%	4024
2021 Q3	$58K	Sell	353 -12	-3%	-$2.28K	﹤0.01%	4078
2021 Q2	$96K	Buy	365 +269	+280%	+$84.6K	﹤0.01%	4160
2021 Q1	$39K	Sell	96 -9	-9%	-$4.02K	﹤0.01%	4286
2020 Q4	$42K	Buy	+105	New	+$32.7K	﹤0.01%	4142

Other funds holding BDSX

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank's BDSX Position: Q2 2022 in Review

Deutsche Bank sold out of Biodesix (BDSX) in Q2 2022, closing a stake of 333 shares — an estimated $11K sold.

Deutsche Bank first reported a position in BDSX in Q4 2020 and held it in 6 quarters. The position peaked at $96K in Q2 2021. 36 funds tracked by Wall St. Rank hold BDSX as of Q2 2022.

Deutsche Bank reported no remaining Biodesix position as of Q2 2022 after selling out during the quarter.
Deutsche Bank sold 333 Biodesix shares in Q2 2022, an estimated $11K.
Deutsche Bank first reported a position in Biodesix in Q4 2020 and held it in 6 quarters.
Deutsche Bank's Biodesix position peaked at $96K in Q2 2021.
36 funds tracked by Wall St. Rank held Biodesix as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.